{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:13:06Z","timestamp":1788865986567,"version":"build-2803163510"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00198-026-08054-x","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:14:14Z","timestamp":1777446854000},"page":"1395-1396","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Letter to the editor concerning \u201cBisphosphonate use is associated with reduced fracture rates in a cohort of patients with Parkinson\u2019s disease\u201d"],"prefix":"10.1007","volume":"37","author":[{"given":"Nan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1522-8661","authenticated-orcid":false,"given":"Kaiying","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"8054_CR1","doi-asserted-by":"crossref","unstructured":"Jang MU, Kim MS, Hwang J, Kim HS, Jo SW, Kim SJ (2026) Bisphosphonate use is associated with reduced fracture rates in a cohort of patients with Parkinson\u2019s disease. Osteoporos Int, 23 Feb\u00a02026\u00a0","DOI":"10.1007\/s00198-026-07906-w"},{"key":"8054_CR2","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1136\/jnnp-2013-307307","volume":"85","author":"KM Torsney","year":"2014","unstructured":"Torsney KM, Noyce AJ, Doherty KM, Bestwick JP, Dobson R, Lees AJ (2014) Bone health in Parkinson\u2019s disease: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 85:1159\u20131166","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8054_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s40263-014-0220-0","volume":"29","author":"N Malek","year":"2015","unstructured":"Malek N, Grosset DG (2015) Medication adherence in patients with Parkinson\u2019s disease. CNS Drugs 29:47\u201353","journal-title":"CNS Drugs"},{"key":"8054_CR4","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1007\/s00198-009-1134-4","volume":"21","author":"I Imaz","year":"2010","unstructured":"Imaz I, Zegarra P, Gonzalez-Enriquez J, Rubio B, Alcazar R, Amate JM (2010) Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis. Osteoporos Int 21:1943\u20131951","journal-title":"Osteoporos Int"},{"key":"8054_CR5","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00198-007-0506-x","volume":"19","author":"V Rabenda","year":"2008","unstructured":"Rabenda V, Mertens R, Fabri V, Vanoverloop J, Sumkay F, Vannecke C, Deswaef A, Verpooten GA, Reginster JY (2008) Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women. Osteoporos Int 19:811\u2013818","journal-title":"Osteoporos Int"},{"key":"8054_CR6","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.jacc.2022.05.045","volume":"80","author":"RA Garcia","year":"2022","unstructured":"Garcia RA, Spertus JA, Benton MC et al (2022) Association of medication adherence with health outcomes in the ISCHEMIA trial. J Am Coll Cardiol 80:755\u2013765","journal-title":"J Am Coll Cardiol"},{"key":"8054_CR7","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1001\/jama.2022.21383","volume":"328","author":"MA Hernan","year":"2022","unstructured":"Hernan MA, Wang W, Leaf DE (2022) Target trial emulation: a framework for causal inference from observational data. JAMA 328:2446\u20132447","journal-title":"JAMA"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-026-08054-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-026-08054-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-026-08054-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:03:34Z","timestamp":1788865414000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-026-08054-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":7,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["8054"],"URL":"https:\/\/doi.org\/10.1007\/s00198-026-08054-x","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"23 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}